[1]
2023. Efficacy and survival analysis of apatinib combined with capecitabine chemotherapy for second-line treatment of advanced esophageal cancer. Indian Journal of Chemical Technology (IJCT). 29, 6 (May 2023), 793–798. DOI:https://doi.org/10.56042/ijct.v29i6.67385.